Evolution of the Average Target: AstraZeneca PLC

Evolution of the Target Price: AstraZeneca PLC

Changes in Analyst Recommendations: AstraZeneca PLC

dfde50b3000b1f842552.87nizGA6PsSyZi5PV42z3VsFT9ZFLmny8gUu2IxzgZA.tY-gr1F7CqfRU2QeBPrGhChJJJoOGiLKlT1o6Ogk8fmF09q6JHxujfEvew~fceac42d00d9ae167a3f9148b66bf0d2
09-04 AstraZeneca: Share price weakness of late, should be capitalised on Alphavalue
09-03 AstraZeneca Kept at Buy as Berenberg Notes Upcoming COPD Data Readout MT
09-02 AstraZeneca PLC : Deutsche Bank reiterates its Sell rating ZD
09-01 AstraZeneca PLC : JP Morgan reaffirms its Buy rating ZD
08-28 AstraZeneca PLC : Jefferies reaffirms its Buy rating ZD
08-25 AstraZeneca PLC : Gets a Sell rating from Deutsche Bank ZD
08-24 JPMorgan raises Diploma, Barclays cuts Unite AN
08-20 Cancer vaccines finally garner the spotlight Alphavalue
08-20 Goldman likes Astra; JPMorgan lowers Trainline AN
08-20 AstraZeneca PLC : Goldman Sachs reaffirms its Buy rating ZD
08-19 AstraZeneca PLC : Deutsche Bank reiterates its Sell rating ZD
08-19 AstraZeneca PLC : UBS reiterates its Buy rating ZD
08-17 BofA Notes AstraZeneca's Volrustomig Late-stage Study Fail; Buy Maintained MT
08-17 AstraZeneca PLC : JP Morgan remains its Buy rating ZD
08-12 A No to BMS can open doors for a Yes to GSK Alphavalue
08-07 AstraZeneca PLC : Jefferies reaffirms its Buy rating ZD
08-04 Bristol Myers Squibb Potential Deal With AstraZeneca Seen Unlikely as Shareholder Views Diverge, RBC Says MT
08-04 ASTRAZENECA : UBS keeps its Buy rating ZD
08-04 ASTRAZENECA : Deutsche Bank keeps a Sell rating ZD
08-03 AstraZeneca Shares 'Likely Remain Depressed' Amid Mega Merger Deal, Berenberg Says; Stock Down 8% MT
08-03 AstraZeneca: BMS acquisition idea holds more red flags than green for AstraZeneca Alphavalue
08-03 ASTRAZENECA : Jefferies keeps its Buy rating ZD
08-03 ASTRAZENECA : Gets a Buy rating from JP Morgan ZD
07-29 ASTRAZENECA : Gets a Buy rating from Bernstein ZD
07-29 Deutsche Bank cuts Diageo and Luceco AN

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+31.21%
+14.46%
+0.15%
+7.85%
+3.73%
-3.15%
-10.87%
+3.62%
+4.25%
+0.55%
Average +5.18%
Weighted average by Cap. +6.70%


Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
24
Last Close Price
162.34USD
Average target price
213.00USD
Spread / Average Target
+31.21%
High Price Target
271.18USD
Spread / Highest target
+67.05%
Low Price Target
151.95USD
Spread / Lowest Target
-6.40%

Analyst Consensus Detail

Consensus revision (last 18 months)

Trader
Investor
Global
Quality
ESG MSCI
A
  1. Stock Market
  2. Stocks
  3. AZN Stock
  4. Consensus AstraZeneca PLC